Leonardo Bonilla da Silveira

Dr. Leonardo Bonilla da Silveira

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 April 2022 in Einstein (São Paulo)
Verified
Journal Article
Open access
PDF file
MRMarina Larissa Vettorello Ramires
Marina Larissa Vettorello Ramires
MLManoela Fidelis Batista Leite
Manoela Fidelis Batista Leite
DLDaniel Zu Yow Lo
Daniel Zu Yow Lo
LSLeonardo Bonilla da Silveira
Leonardo Bonilla da Silveira
LFLeonardo José Rolim Ferraz
Leonardo José Rolim Ferraz
MGMiguel Angelo Goes
Miguel Angelo Goes
Objective The objective of the present study is to evaluate the association of red blood cell distribution width with acute kidney injury in sepsis. Methods This is a retrospective study of 849 critically ill patients with sepsis in intensive care unit. Demographic data, renal function, inflammation, complete blood count, and acid-base parameters were compared between acute kidney injury and non-acute kidney injury groups. Therefore, a multivariate analysis was performed to observe independent predictive factors. Results Comparatively, higher levels of

16 February 2024 in Viruses
Verified
Journal Article
Open access
PDF file
Michelle ZickerMichelle Zicker
Michelle Zicker
João Renato Rebello PinhoJoão Renato Rebello Pinho
João Renato Rebello Pinho
EREliane Aparecida Rosseto
Eliane Aparecida Rosseto
BGBianca Guardia
Bianca Guardia
PSPaulo Gabriel Thomaz Matias Da Silva
Paulo Gabriel Thomaz Matias Da Silva
LCLuís Camargo
Luís Camargo
The hepatitis E virus is a major etiological agent of chronic hepatitis in immunosuppressed individuals. Seroprevalence in the liver transplantation setting varies according to the seroprevalence of the general population in different countries. This was a prospective cohort study of liver transplant recipients in southeastern Brazil. Recipients were systematically followed for one year, with the objective of determining the prevalence, incidence, and natural history of HEV infection in this population. We included 107 liver transplant recipients and 83 deceased donors. Positivity for anti-HEV IgG was detected in 10.2% of the recipients and in 9.7% of the donors. None of the patients tested positive for HEV RNA at baseline or during follow-up. There were no episodes of reactivation or seroconversion, even in cases of serological donor-recipient mismatch or in recipients with acute hepatitis. Acute and chronic HEV infections seem to be rare events in the region studied. That could be attributable to social, economic, and environmental factors. Our data indicate that, among liver transplant recipients, hepatitis E should be investigated only when there are elevated levels of transaminases with no defined cause, as part of the differential diagnosis of seronegative hepatitis after transplantation.